Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Drug Alcohol Depend. 2012 Nov 10;130(0):68–76. doi: 10.1016/j.drugalcdep.2012.10.011

Figure 1.

Figure 1

Study design. Participants (n=14) received in random order, 1 of 5 treatments: synthetic 5 mg Δ9-tetrahydrocannabinol (THC); synthetic 15 mg THC; 2 actuations of Sativex (5.4 mg THC and 5 mg cannabidiol (CBD)); 6 actuations of Sativex (16.2 mg THC + 15 mg CBD); or placebo synthetic THC and placebo Sativex.